(VIANEWS) – Innrs Artificial Intelligence has been accurately guessing the intraday stock prices and making several successful predictions.
Via News will publish the daily results of this AI algorithm.
If an investor followed the Innrs AI suggestion, yesterday’s AI investment would yield a 0.89% ROI.
The table below shows the data.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| General Motors (GM) | 93.18% | $34.45 | 4.45% ✅ |
| Hasbro (HAS) | 93.63% | $51.67 | 3.13% ✅ |
| argenx SE (ARGX) | 88.77% | $380.23 | 2.54% ✅ |
| Fomento Economico Mexicano S.A.B. de C.V. (FMX) | 88.99% | $94.49 | 1.97% ✅ |
| Baxter International (BAX) | 88.85% | $40.74 | 1.68% ✅ |
| Visa (V) | 93.64% | $223.58 | 1.57% ✅ |
| Martin Marietta Materials (MLM) | 88.34% | $357.01 | 1.4% ✅ |
| CVS Health (CVS) | 88.15% | $75.2 | 1.38% ✅ |
| Arthur J. Gallagher & Co. (AJG) | 88.25% | $191.12 | 1.32% ✅ |
| Toyota (TM) | 88.67% | $141.57 | 1.31% ✅ |
| Genmab (GMAB) | 89.39% | $37.65 | 1.21% ✅ |
| Verizon (VZ) | 89.23% | $39.05 | 1.18% ✅ |
| Aon plc (AON) | 87.87% | $318.28 | 1.15% ✅ |
| Mondelez International (MDLZ) | 89.22% | $69.88 | 1.11% ✅ |
| Honda (HMC) | 89.47% | $26.14 | 1.08% ✅ |
| Berkshire Hathaway (BRK-B) | 88.65% | $310.48 | 1.04% ✅ |
| HCA Holdings (HCA) | 88.86% | $259.33 | 1.02% ✅ |
| Celsius Holdings (CELH) | 88.01% | $92.73 | 0.92% ✅ |
| Novo Nordisk A/S (NVO) | 88.05% | $160.68 | 0.85% ✅ |
| Toronto Dominion Bank (TD) | 88.51% | $59.98 | 0.8% ✅ |
| Pepsico (PEP) | 87.95% | $182.77 | 0.67% ✅ |
| Bio-Techne Corp (TECH) | 89.02% | $72.56 | 0.66% ✅ |
| PerkinElmer (PKI) | 88.31% | $133.47 | 0.63% ✅ |
| Quidel (QDEL) | 88.8% | $90.26 | 0.54% ✅ |
| Rogers Communication (RCI) | 88.93% | $47.48 | 0.45% ✅ |
| General Mills (GIS) | 88.8% | $85.83 | 0.43% ✅ |
| Danaher Corporation (DHR) | 88.06% | $254.64 | 0.31% ✅ |
| Astrazeneca (AZN) | 88.37% | $70.24 | 0.03% ✅ |
| GlaxoSmithKline (GSK) | 93.89% | $35.91 | -0.17% |
| Match Group (MTCH) | 93.32% | $40.63 | -0.81% |
| Novartis AG (NVS) | 88.2% | $92.05 | -0.86% |
| Atrion (ATRI) | 88.45% | $657.72 | -4.54% |
1. General Motors (GM)
General Motors has been having an accuracy rate of 93.18% over the last 10 sessions. Previous close price was $34.18 the AI prediction was $34.45 and today’s closing price was $35.7. The intraday ROI for General Motors (GM) was 4.45%.
Shares of General Motors fell 8.85% in from $39.16 to $35.69 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide.
Earnings Per Share
As for profitability, General Motors has a trailing twelve months EPS of $4.33.
PE Ratio
General Motors has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing $8.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.06%.
Volume
Today’s last reported volume for General Motors is 10039400 which is 35.91% below its average volume of 15665800.
Volatility
General Motors’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.48%, a negative 0.70%, and a positive 1.80%.
General Motors’s highest amplitude of average volatility was 0.99% (last week), 2.03% (last month), and 1.80% (last quarter).
Moving Average
General Motors’s value is under its 50-day moving average of $38.34 and under its 200-day moving average of $36.92.
More news about General Motors.
2. Hasbro (HAS)
Hasbro has been having an accuracy rate of 93.63% over the last 10 sessions. Previous close price was $50.42 the AI prediction was $51.67 and today’s closing price was $52. The intraday ROI for Hasbro (HAS) was 3.13%.
Shares of Hasbro dropped 5.65% in from $55.12 to $52.01 at 22:29 EST on Wednesday, after four successive sessions in a row of gains. NASDAQ is jumping 1.79% to $11,926.24, following the last session’s upward trend.
Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company.
Earnings Per Share
As for profitability, Hasbro has a trailing twelve months EPS of $2.97.
PE Ratio
Hasbro has a trailing twelve months price to earnings ratio of 17.53. Meaning, the purchaser of the share is investing $17.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.7%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Hasbro’s stock is considered to be oversold (<=20).
Volatility
Hasbro’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.69%, a negative 0.37%, and a positive 1.89%.
Hasbro’s highest amplitude of average volatility was 1.69% (last week), 1.95% (last month), and 1.89% (last quarter).
More news about Hasbro.
3. argenx SE (ARGX)
argenx SE has been having an accuracy rate of 88.77% over the last 10 sessions. Previous close price was $367.15 the AI prediction was $380.23 and today’s closing price was $376.47. The intraday ROI for argenx SE (ARGX) was 2.54%.
Shares of argenx SE rose 2.93% in from $365.65 to $376.36 at 22:29 EST on Wednesday, after five consecutive sessions in a row of gains. NASDAQ is rising 1.79% to $11,926.24, following the last session’s upward trend.
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France.
Earnings Per Share
As for profitability, argenx SE has a trailing twelve months EPS of $-14.04.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 49.6% and 44.7%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, argenx SE’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for argenx SE is 285951 which is 24.85% above its average volume of 229035.
More news about argenx SE.
4. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
Fomento Economico Mexicano S.A.B. de C.V. has been having an accuracy rate of 88.99% over the last 10 sessions. Previous close price was $93.04 the AI prediction was $94.49 and today’s closing price was $94.87. The intraday ROI for Fomento Economico Mexicano S.A.B. de C.V. (FMX) was 1.97%.
Shares of Fomento Economico Mexicano S.A.B. de C.V. jumped 3.16% in from $92.01 to $94.92 at 22:29 EST on Wednesday, after five sequential sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four sequential sessions in a row of gains.
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $-0.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.26%.
Moving Average
Fomento Economico Mexicano S.A.B. de C.V.’s worth is above its 50-day moving average of $87.90 and way higher than its 200-day moving average of $73.63.
More news about Fomento Economico Mexicano S.A.B. de C.V..
5. Baxter International (BAX)
Baxter International has been having an accuracy rate of 88.85% over the last 10 sessions. Previous close price was $39.87 the AI prediction was $40.74 and today’s closing price was $40.54. The intraday ROI for Baxter International (BAX) was 1.68%.
Shares of Baxter International rose 1.37% in from $40.03 to $40.58 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
Earnings Per Share
As for profitability, Baxter International has a trailing twelve months EPS of $2.07.
PE Ratio
Baxter International has a trailing twelve months price to earnings ratio of 19.61. Meaning, the purchaser of the share is investing $19.61 for every dollar of annual earnings.
Yearly Top and Bottom Value
Baxter International’s stock is valued at $40.58 at 22:29 EST, way under its 52-week high of $80.72 and above its 52-week low of $37.35.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Baxter International’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Baxter International is 3225300 which is 50.58% below its average volume of 6526750.
More news about Baxter International.
6. Visa (V)
Visa has been having an accuracy rate of 93.64% over the last 10 sessions. Previous close price was $219.84 the AI prediction was $223.58 and today’s closing price was $223.3. The intraday ROI for Visa (V) was 1.57%.
Shares of Visa jumped 1.62% in from $219.86 to $223.42 at 22:29 EST on Wednesday, after two successive sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
Visa Inc. operates as a payments technology company worldwide.
Earnings Per Share
As for profitability, Visa has a trailing twelve months EPS of $4.84.
PE Ratio
Visa has a trailing twelve months price to earnings ratio of 46.18. Meaning, the purchaser of the share is investing $46.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.51%.
Sales Growth
Visa’s sales growth is 8.1% for the present quarter and 10.3% for the next.
More news about Visa.
7. Martin Marietta Materials (MLM)
Martin Marietta Materials has been having an accuracy rate of 88.34% over the last 10 sessions. Previous close price was $346.39 the AI prediction was $357.01 and today’s closing price was $351.24. The intraday ROI for Martin Marietta Materials (MLM) was 1.4%.
Shares of Martin Marietta Materials fell 2.75% in from $360.8 to $350.88 at 22:29 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four successive sessions in a row of gains.
Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally.
Earnings Per Share
As for profitability, Martin Marietta Materials has a trailing twelve months EPS of $11.54.
PE Ratio
Martin Marietta Materials has a trailing twelve months price to earnings ratio of 30.41. Meaning, the purchaser of the share is investing $30.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.41%.
More news about Martin Marietta Materials.
8. CVS Health (CVS)
CVS Health has been having an accuracy rate of 88.15% over the last 10 sessions. Previous close price was $73.08 the AI prediction was $75.2 and today’s closing price was $74.09. The intraday ROI for CVS Health (CVS) was 1.38%.
Shares of CVS Health fell by a staggering 12.95% in from $85.07 to $74.05 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is rising 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
CVS Health Corporation provides health services in the United States.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $5.46.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 13.55. Meaning, the purchaser of the share is investing $13.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.68%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 18, 2023, the estimated forward annual dividend rate is 2.42 and the estimated forward annual dividend yield is 2.72%.
Volume
Today’s last reported volume for CVS Health is 5265810 which is 42.82% below its average volume of 9210270.
Sales Growth
CVS Health’s sales growth is 3.8% for the present quarter and 2.3% for the next.
More news about CVS Health.
9. Arthur J. Gallagher & Co. (AJG)
Arthur J. Gallagher & Co. has been having an accuracy rate of 88.25% over the last 10 sessions. Previous close price was $186.54 the AI prediction was $191.12 and today’s closing price was $189. The intraday ROI for Arthur J. Gallagher & Co. (AJG) was 1.32%.
Shares of Arthur J. Gallagher & Co. rose 0.68% in from $187.51 to $188.79 at 22:29 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four successive sessions in a row of gains.
Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance brokerage, consulting, third-party claims settlement, and administration services in the United States, Australia, Bermuda, Canada, the Caribbean, New Zealand, India, and the United Kingdom.
Earnings Per Share
As for profitability, Arthur J. Gallagher & Co. has a trailing twelve months EPS of $4.35.
PE Ratio
Arthur J. Gallagher & Co. has a trailing twelve months price to earnings ratio of 43.36. Meaning, the purchaser of the share is investing $43.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.57%.
Moving Average
Arthur J. Gallagher & Co.’s value is under its 50-day moving average of $189.71 and higher than its 200-day moving average of $182.42.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.2%, now sitting on 8.27B for the twelve trailing months.
More news about Arthur J. Gallagher & Co..
10. Toyota (TM)
Toyota has been having an accuracy rate of 88.67% over the last 10 sessions. Previous close price was $137.86 the AI prediction was $141.57 and today’s closing price was $139.67. The intraday ROI for Toyota (TM) was 1.31%.
Shares of Toyota jumped 2.68% in from $136.02 to $139.67 at 22:29 EST on Wednesday, after five sequential sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four sequential sessions in a row of gains.
Toyota Motor Corporation designs, manufactures, assembles, and sells passenger vehicles, minivans and commercial vehicles, and related parts and accessories.
Earnings Per Share
As for profitability, Toyota has a trailing twelve months EPS of $9.96.
PE Ratio
Toyota has a trailing twelve months price to earnings ratio of 14.03. Meaning, the purchaser of the share is investing $14.03 for every dollar of annual earnings.
Moving Average
Toyota’s value is below its 50-day moving average of $141.40 and below its 200-day moving average of $146.66.
More news about Toyota.
11. Genmab (GMAB)
Genmab has been having an accuracy rate of 89.39% over the last 10 sessions. Previous close price was $37.12 the AI prediction was $37.65 and today’s closing price was $37.57. The intraday ROI for Genmab (GMAB) was 1.21%.
Shares of Genmab jumped 0.16% in from $37.56 to $37.62 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is rising 1.79% to $11,926.24, following the last session’s upward trend.
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark.
Earnings Per Share
As for profitability, Genmab has a trailing twelve months EPS of $0.66.
PE Ratio
Genmab has a trailing twelve months price to earnings ratio of 56.9. Meaning, the purchaser of the share is investing $56.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.59%.
More news about Genmab.
12. Verizon (VZ)
Verizon has been having an accuracy rate of 89.23% over the last 10 sessions. Previous close price was $38.03 the AI prediction was $39.05 and today’s closing price was $38.48. The intraday ROI for Verizon (VZ) was 1.18%.
Shares of Verizon fell 1.12% in from $38.91 to $38.47 at 22:29 EST on Wednesday, after two successive sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four successive sessions in a row of gains.
Verizon Communications Inc., through its subsidiaries, provides communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide.
Earnings Per Share
As for profitability, Verizon has a trailing twelve months EPS of $4.56.
PE Ratio
Verizon has a trailing twelve months price to earnings ratio of 8.43. Meaning, the purchaser of the share is investing $8.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.76%.
Volume
Today’s last reported volume for Verizon is 8569390 which is 59.27% below its average volume of 21040900.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 8, 2023, the estimated forward annual dividend rate is 2.61 and the estimated forward annual dividend yield is 6.46%.
More news about Verizon.
13. Aon plc (AON)
Aon plc has been having an accuracy rate of 87.87% over the last 10 sessions. Previous close price was $309.13 the AI prediction was $318.28 and today’s closing price was $312.69. The intraday ROI for Aon plc (AON) was 1.15%.
Shares of Aon plc rose 2.52% in from $304.64 to $312.32 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is rising 1.17% to $15,123.96, after four successive sessions in a row of gains.
Aon plc, a professional services firm, provides advice and solutions to clients focused on risk, retirement, and health worldwide.
Earnings Per Share
As for profitability, Aon plc has a trailing twelve months EPS of $9.12.
PE Ratio
Aon plc has a trailing twelve months price to earnings ratio of 34.24. Meaning, the purchaser of the share is investing $34.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 725.93%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aon plc’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Aon plc’s stock is valued at $312.32 at 22:29 EST, below its 52-week high of $341.98 and way above its 52-week low of $246.21.
More news about Aon plc.
14. Mondelez International (MDLZ)
Mondelez International has been having an accuracy rate of 89.22% over the last 10 sessions. Previous close price was $69.6 the AI prediction was $69.88 and today’s closing price was $70.37. The intraday ROI for Mondelez International (MDLZ) was 1.11%.
Shares of Mondelez International rose 7.78% in from $65.29 to $70.37 at 22:29 EST on Wednesday, after four consecutive sessions in a row of gains. NASDAQ is jumping 1.79% to $11,926.24, following the last session’s upward trend.
Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe.
Earnings Per Share
As for profitability, Mondelez International has a trailing twelve months EPS of $2.64.
PE Ratio
Mondelez International has a trailing twelve months price to earnings ratio of 26.66. Meaning, the purchaser of the share is investing $26.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Sales Growth
Mondelez International’s sales growth is 9.5% for the current quarter and 9.8% for the next.
More news about Mondelez International.
15. Honda (HMC)
Honda has been having an accuracy rate of 89.47% over the last 10 sessions. Previous close price was $25.85 the AI prediction was $26.14 and today’s closing price was $26.13. The intraday ROI for Honda (HMC) was 1.08%.
Shares of Honda rose 0.58% in from $26 to $26.15 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
Honda Motor Co., Ltd.
Earnings Per Share
As for profitability, Honda has a trailing twelve months EPS of $2.2.
PE Ratio
Honda has a trailing twelve months price to earnings ratio of 11.9. Meaning, the purchaser of the share is investing $11.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.66%.
Moving Average
Honda’s worth is above its 50-day moving average of $25.19 and above its 200-day moving average of $24.49.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 27, 2022, the estimated forward annual dividend rate is 1.42 and the estimated forward annual dividend yield is 5.8%.
Volatility
Honda’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.28%, a negative 0.05%, and a positive 1.09%.
Honda’s highest amplitude of average volatility was 0.31% (last week), 1.13% (last month), and 1.09% (last quarter).
More news about Honda.
16. Berkshire Hathaway (BRK-B)
Berkshire Hathaway has been having an accuracy rate of 88.65% over the last 10 sessions. Previous close price was $302.17 the AI prediction was $310.48 and today’s closing price was $305.3. The intraday ROI for Berkshire Hathaway (BRK-B) was 1.04%.
Shares of Berkshire Hathaway fell 0.23% in from $305.65 to $304.95 at 22:29 EST on Wednesday, after four successive sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide.
Earnings Per Share
As for profitability, Berkshire Hathaway has a trailing twelve months EPS of $66140.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Berkshire Hathaway’s stock is considered to be oversold (<=20).
Sales Growth
Berkshire Hathaway’s sales growth is 9.5% for the current quarter and 12.6% for the next.
Previous days news about Berkshire Hathaway
- : occidental petroleum stock surges after upgrade at TD cowen, which includes large investment by warren buffett’s Berkshire Hathaway as a reason to be bullish. According to MarketWatch on Tuesday, 28 March, "He listed a number of reasons for his bullishness, such as "superior" exposure to crude oil pricing, capital structure shifts, a favorable free cash flow yield, well productivity and "captive buying support" from Warren Buffett’s Berkshire Hathaway Inc. , which has been steadily increasing its stake in the company since early 2022 to be Occidental’s largest shareholder. "
More news about Berkshire Hathaway.
17. HCA Holdings (HCA)
HCA Holdings has been having an accuracy rate of 88.86% over the last 10 sessions. Previous close price was $254.76 the AI prediction was $259.33 and today’s closing price was $257.36. The intraday ROI for HCA Holdings (HCA) was 1.02%.
Shares of HCA Holdings jumped 5.85% in from $243.32 to $257.55 at 22:29 EST on Wednesday, after four sequential sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four successive sessions in a row of gains.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.
Earnings Per Share
As for profitability, HCA Holdings has a trailing twelve months EPS of $13.38.
PE Ratio
HCA Holdings has a trailing twelve months price to earnings ratio of 19.25. Meaning, the purchaser of the share is investing $19.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 965.25%.
Yearly Top and Bottom Value
HCA Holdings’s stock is valued at $257.55 at 22:29 EST, below its 52-week high of $279.02 and way higher than its 52-week low of $164.47.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HCA Holdings’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 2.7% and positive 1.9% for the next.
More news about HCA Holdings.
18. Celsius Holdings (CELH)
Celsius Holdings has been having an accuracy rate of 88.01% over the last 10 sessions. Previous close price was $89.79 the AI prediction was $92.73 and today’s closing price was $90.62. The intraday ROI for Celsius Holdings (CELH) was 0.92%.
Shares of Celsius Holdings fell 0.62% in from $91.27 to $90.70 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is rising 1.79% to $11,926.24, following the last session’s upward trend.
Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally.
Earnings Per Share
As for profitability, Celsius Holdings has a trailing twelve months EPS of $0.11.
PE Ratio
Celsius Holdings has a trailing twelve months price to earnings ratio of 824.55. Meaning, the purchaser of the share is investing $824.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.51%.
More news about Celsius Holdings.
19. Novo Nordisk A/S (NVO)
Novo Nordisk A/S has been having an accuracy rate of 88.05% over the last 10 sessions. Previous close price was $155.26 the AI prediction was $160.68 and today’s closing price was $156.58. The intraday ROI for Novo Nordisk A/S (NVO) was 0.85%.
Shares of Novo Nordisk A/S rose by a staggering 10.83% in from $141.3 to $156.60 at 22:29 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.
Earnings Per Share
As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $2.92.
PE Ratio
Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 53.63. Meaning, the purchaser of the share is investing $53.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72%.
Volume
Today’s last reported volume for Novo Nordisk A/S is 766970 which is 46.53% below its average volume of 1434640.
More news about Novo Nordisk A/S.
20. Toronto Dominion Bank (TD)
Toronto Dominion Bank has been having an accuracy rate of 88.51% over the last 10 sessions. Previous close price was $58.75 the AI prediction was $59.98 and today’s closing price was $59.22. The intraday ROI for Toronto Dominion Bank (TD) was 0.8%.
Shares of Toronto Dominion Bank slid by a staggering 12.59% in from $67.72 to $59.19 at 22:29 EST on Wednesday, after five sequential sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
The Toronto-Dominion Bank, together with its subsidiaries, provides various financial products and services in Canada, the United States, and internationally.
Earnings Per Share
As for profitability, Toronto Dominion Bank has a trailing twelve months EPS of $5.37.
PE Ratio
Toronto Dominion Bank has a trailing twelve months price to earnings ratio of 11.03. Meaning, the purchaser of the share is investing $11.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.5%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 1.9% and 3.8%, respectively.
Yearly Top and Bottom Value
Toronto Dominion Bank’s stock is valued at $59.19 at 22:29 EST, way below its 52-week high of $82.64 and higher than its 52-week low of $57.27.
Volatility
Toronto Dominion Bank’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.39%, a negative 0.60%, and a positive 1.05%.
Toronto Dominion Bank’s highest amplitude of average volatility was 1.39% (last week), 1.33% (last month), and 1.05% (last quarter).
More news about Toronto Dominion Bank.
21. Pepsico (PEP)
Pepsico has been having an accuracy rate of 87.95% over the last 10 sessions. Previous close price was $179.46 the AI prediction was $182.77 and today’s closing price was $180.67. The intraday ROI for Pepsico (PEP) was 0.67%.
Shares of Pepsico jumped 4.1% in from $173.45 to $180.56 at 22:29 EST on Wednesday, after two successive sessions in a row of gains. NASDAQ is rising 1.79% to $11,926.24, following the last session’s upward trend.
PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide.
Earnings Per Share
As for profitability, Pepsico has a trailing twelve months EPS of $5.4.
PE Ratio
Pepsico has a trailing twelve months price to earnings ratio of 33.42. Meaning, the purchaser of the share is investing $33.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 55.71%.
More news about Pepsico.
22. Bio-Techne Corp (TECH)
Bio-Techne Corp has been having an accuracy rate of 89.02% over the last 10 sessions. Previous close price was $71.59 the AI prediction was $72.56 and today’s closing price was $72.06. The intraday ROI for Bio-Techne Corp (TECH) was 0.66%.
Shares of Bio-Techne Corp fell 1.14% in from $72.93 to $72.10 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is jumping 1.79% to $11,926.24, following the last session’s upward trend.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.
Earnings Per Share
As for profitability, Bio-Techne Corp has a trailing twelve months EPS of $4.4.
PE Ratio
Bio-Techne Corp has a trailing twelve months price to earnings ratio of 16.4. Meaning, the purchaser of the share is investing $16.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.83%.
Yearly Top and Bottom Value
Bio-Techne Corp’s stock is valued at $72.10 at 22:29 EST, way under its 52-week high of $113.81 and higher than its 52-week low of $68.00.
Volume
Today’s last reported volume for Bio-Techne Corp is 337741 which is 66.22% below its average volume of 999908.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 9, 2023, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 0.42%.
More news about Bio-Techne Corp.
23. PerkinElmer (PKI)
PerkinElmer has been having an accuracy rate of 88.31% over the last 10 sessions. Previous close price was $128.59 the AI prediction was $133.47 and today’s closing price was $129.4. The intraday ROI for PerkinElmer (PKI) was 0.63%.
Shares of PerkinElmer rose 4.79% in from $123.92 to $129.86 at 22:29 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four sequential sessions in a row of gains.
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide.
Earnings Per Share
As for profitability, PerkinElmer has a trailing twelve months EPS of $6.5.
PE Ratio
PerkinElmer has a trailing twelve months price to earnings ratio of 19.98. Meaning, the purchaser of the share is investing $19.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
More news about PerkinElmer.
24. Quidel (QDEL)
Quidel has been having an accuracy rate of 88.8% over the last 10 sessions. Previous close price was $87.39 the AI prediction was $90.26 and today’s closing price was $87.86. The intraday ROI for Quidel (QDEL) was 0.54%.
Shares of Quidel jumped 0.83% in from $86.97 to $87.69 at 22:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is rising 1.79% to $11,926.24, following the last session’s upward trend.
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs.
Earnings Per Share
As for profitability, Quidel has a trailing twelve months EPS of $18.6.
PE Ratio
Quidel has a trailing twelve months price to earnings ratio of 4.71. Meaning, the purchaser of the share is investing $4.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.19%.
Moving Average
Quidel’s value is above its 50-day moving average of $86.90 and below its 200-day moving average of $87.96.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 80.4% and a negative 81.6%, respectively.
Volatility
Quidel’s last week, last month’s, and last quarter’s current intraday variation average was 0.79%, 0.12%, and 1.55%.
Quidel’s highest amplitude of average volatility was 1.08% (last week), 1.31% (last month), and 1.55% (last quarter).
More news about Quidel.
25. Rogers Communication (RCI)
Rogers Communication has been having an accuracy rate of 88.93% over the last 10 sessions. Previous close price was $46.64 the AI prediction was $47.48 and today’s closing price was $46.85. The intraday ROI for Rogers Communication (RCI) was 0.45%.
Shares of Rogers Communication slid 2.16% in from $47.88 to $46.85 at 22:29 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is jumping 1.17% to $15,123.96, after four sequential sessions in a row of gains.
Rogers Communications Inc. operates as a communications and media company in Canada.
Earnings Per Share
As for profitability, Rogers Communication has a trailing twelve months EPS of $2.57.
PE Ratio
Rogers Communication has a trailing twelve months price to earnings ratio of 18.21. Meaning, the purchaser of the share is investing $18.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.29%.
More news about Rogers Communication.
26. General Mills (GIS)
General Mills has been having an accuracy rate of 88.8% over the last 10 sessions. Previous close price was $84.67 the AI prediction was $85.83 and today’s closing price was $85.03. The intraday ROI for General Mills (GIS) was 0.43%.
Shares of General Mills jumped 6.24% in from $79.79 to $84.77 at 22:29 EST on Wednesday, after two consecutive sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
General Mills, Inc. manufactures and markets branded consumer foods worldwide.
Earnings Per Share
As for profitability, General Mills has a trailing twelve months EPS of $4.12.
PE Ratio
General Mills has a trailing twelve months price to earnings ratio of 20.58. Meaning, the purchaser of the share is investing $20.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.16%.
More news about General Mills.
27. Danaher Corporation (DHR)
Danaher Corporation has been having an accuracy rate of 88.06% over the last 10 sessions. Previous close price was $246.71 the AI prediction was $254.64 and today’s closing price was $247.48. The intraday ROI for Danaher Corporation (DHR) was 0.31%.
Shares of Danaher Corporation jumped 0.07% in from $247.83 to $248.00 at 22:29 EST on Wednesday, after two successive sessions in a row of gains. NYSE is rising 1.17% to $15,123.96, after four sequential sessions in a row of gains.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
Earnings Per Share
As for profitability, Danaher Corporation has a trailing twelve months EPS of $6.37.
PE Ratio
Danaher Corporation has a trailing twelve months price to earnings ratio of 38.96. Meaning, the purchaser of the share is investing $38.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.13%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 28, 2022, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 0.39%.
Moving Average
Danaher Corporation’s worth is under its 50-day moving average of $256.66 and below its 200-day moving average of $264.07.
Yearly Top and Bottom Value
Danaher Corporation’s stock is valued at $248.00 at 22:29 EST, way under its 52-week high of $303.82 and above its 52-week low of $233.71.
More news about Danaher Corporation.
28. Astrazeneca (AZN)
Astrazeneca has been having an accuracy rate of 88.37% over the last 10 sessions. Previous close price was $68.62 the AI prediction was $70.24 and today’s closing price was $68.64. The intraday ROI for Astrazeneca (AZN) was 0.03%.
Shares of Astrazeneca jumped 5.26% in from $65.21 to $68.64 at 22:29 EST on Wednesday, following the last session’s upward trend. NYSE is jumping 1.17% to $15,123.96, after four consecutive sessions in a row of gains.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.52.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 45.29. Meaning, the purchaser of the share is investing $45.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.45%.
Volume
Today’s last reported volume for Astrazeneca is 3885080 which is 24.94% below its average volume of 5176480.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.7%, now sitting on 45.16B for the twelve trailing months.
Sales Growth
Astrazeneca’s sales growth is negative 3.8% for the ongoing quarter and 4.8% for the next.
More news about Astrazeneca.
29. GlaxoSmithKline (GSK)
GlaxoSmithKline has been having an accuracy rate of 93.89% over the last 10 sessions. Previous close price was $35.12 the AI prediction was $35.91 and today’s closing price was $35.06. The intraday ROI for GlaxoSmithKline (GSK) was -0.17%.
Shares of GlaxoSmithKline jumped 2.1% in from $34.33 to $35.05 at 22:29 EST on Wednesday, following the last session’s downward trend. NYSE is jumping 1.17% to $15,123.96, after four sequential sessions in a row of gains.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.88.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 12.17. Meaning, the purchaser of the share is investing $12.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.31%.
Volatility
GlaxoSmithKline’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.12%, a positive 0.12%, and a positive 0.93%.
GlaxoSmithKline’s highest amplitude of average volatility was 1.51% (last week), 0.86% (last month), and 0.93% (last quarter).
More news about GlaxoSmithKline.
30. Match Group (MTCH)
Match Group has been having an accuracy rate of 93.32% over the last 10 sessions. Previous close price was $39.49 the AI prediction was $40.63 and today’s closing price was $39.17. The intraday ROI for Match Group (MTCH) was -0.81%.
Shares of Match Group fell 5.57% in from $41.46 to $39.15 at 22:29 EST on Wednesday, after three sequential sessions in a row of losses. NASDAQ is jumping 1.79% to $11,926.24, following the last session’s upward trend.
Match Group, Inc. provides dating products worldwide.
Earnings Per Share
As for profitability, Match Group has a trailing twelve months EPS of $0.49.
PE Ratio
Match Group has a trailing twelve months price to earnings ratio of 80.23. Meaning, the purchaser of the share is investing $80.23 for every dollar of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.5%, now sitting on 3.19B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 31.7% and positive 554.5% for the next.
More news about Match Group.
31. Novartis AG (NVS)
Novartis AG has been having an accuracy rate of 88.2% over the last 10 sessions. Previous close price was $90.97 the AI prediction was $92.05 and today’s closing price was $90.19. The intraday ROI for Novartis AG (NVS) was -0.86%.
Shares of Novartis AG rose 7.14% in from $84.18 to $90.19 at 22:29 EST on Wednesday, after two successive sessions in a row of losses. NYSE is jumping 1.17% to $15,123.96, after four successive sessions in a row of gains.
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $3.48.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 25.92. Meaning, the purchaser of the share is investing $25.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Yearly Top and Bottom Value
Novartis AG’s stock is valued at $90.19 at 22:29 EST, below its 52-week high of $94.26 and way above its 52-week low of $74.09.
More news about Novartis AG.
32. Atrion (ATRI)
Atrion has been having an accuracy rate of 88.45% over the last 10 sessions. Previous close price was $641 the AI prediction was $657.72 and today’s closing price was $611.88. The intraday ROI for Atrion (ATRI) was -4.54%.
Shares of Atrion jumped 4.35% in from $594.15 to $620.00 at 22:29 EST on Wednesday, after three successive sessions in a row of losses. NASDAQ is jumping 1.79% to $11,926.24, following the last session’s upward trend.
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally.
Earnings Per Share
As for profitability, Atrion has a trailing twelve months EPS of $17.44.
PE Ratio
Atrion has a trailing twelve months price to earnings ratio of 35.55. Meaning, the purchaser of the share is investing $35.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 180.94M for the twelve trailing months.
Yearly Top and Bottom Value
Atrion’s stock is valued at $620.00 at 22:29 EST, way under its 52-week high of $766.72 and way above its 52-week low of $534.99.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 29, 2022, the estimated forward annual dividend rate is 8.6 and the estimated forward annual dividend yield is 1.28%.
Moving Average
Atrion’s worth is below its 50-day moving average of $647.40 and under its 200-day moving average of $621.28.
More news about Atrion.
